3M is playing a critical role in the global response to COVID-19. Now, more than ever, 3M's Commercial Solutions Division understands ensuring a clean and healthy facility is critical. It requires navigating new coronavirus cleaning and disinfection protocols and making sure personnel are properly trained.

Recently, the U.S. EPA started to approve disinfectants for the adoption of a SARS-CoV-2, the virus that causes COVID-19, efficacy claim. The 3M™ Disinfectant RCT Cleaner Concentrate (#40), 3M™ Quat Disinfectant Cleaner Concentrate (#5), and the 3M™ TB Quat Disinfectant Ready-To-Use Cleaner have been approved for the adoption of a SARS-CoV-2 efficacy claim. These approvals are part of the EPA's efforts to provide the public with information on how to safely and effectively protect against the novel coronavirus, SARS-CoV-2, on surfaces.

These EPA approvals reflect 3M's commitment to developing innovative cleaning and disinfectant solutions that meet the needs of customers. Even with EPA approvals, 3M emphasizes that proper product use is critical to the effective and safe use of any disinfectant. When using a disinfectant, customers are instructed to follow label directions, including dwell time, for safe, effective use.

To contact an expert and find additional information about 3M disinfectants and keeping your facility safe and healthy during the pandemic, visit 3m.com/disinfection.